Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Rubin

Showing results (41-50 of 566) with videos related to

Pageof 57
Sort By:
Gastrointestinal Endoscopy|September 16, 2018
ResponseNoa Krugliak Cleveland, David T Rubin
Journal of Crohn'S & Colitis|January 25, 2015
Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel diseaseRuben J Colman, David T Rubin
Gastrointestinal Endoscopy Clinics of North America|November 7, 2024
Endoscopy in Inflammatory Bowel Disease: Indications, Timing, and Biopsy ProtocolJoëlle St-Pierre, David T Rubin
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 3, 2024
The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel DiseaseJordan E Axelrad, David T Rubin
The American Journal of Gastroenterology|June 3, 2005
Will a 5-ASA a day keep the cancer (and dysplasia) away?David T Rubin, Bret A Lashner
The American Journal of Gastroenterology|June 8, 2021
Response to Tetangco and HanauerSeth R Shaffer, David T Rubin
The Medical Clinics of North America|December 1, 2009
Novel diagnostic and prognostic modalities in inflammatory bowel diseaseTimothy L Zisman, David T Rubin
Gastroenterology Clinics of North America|November 17, 2009
Novel diagnostic and prognostic modalities in inflammatory bowel diseaseTimothy L Zisman, David T Rubin
The American Journal of Gastroenterology|April 8, 2015
Using a Treat-to-Target Management Strategy to Improve the Doctor-Patient Relationship in Inflammatory Bowel DiseaseDavid T Rubin, Noa Krugliak Cleveland
Gastrointestinal Endoscopy Clinics of North America|July 1, 2014
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel diseaseChristopher G Chapman, David T Rubin
Pageof 57

Showing results (41-50 of 566) with videos related to

Sort By:
Pageof 57
Gastrointestinal Endoscopy|September 16, 2018
ResponseNoa Krugliak Cleveland, David T Rubin
Journal of Crohn'S & Colitis|January 25, 2015
Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel diseaseRuben J Colman, David T Rubin
Gastrointestinal Endoscopy Clinics of North America|November 7, 2024
Endoscopy in Inflammatory Bowel Disease: Indications, Timing, and Biopsy ProtocolJoëlle St-Pierre, David T Rubin
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 3, 2024
The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel DiseaseJordan E Axelrad, David T Rubin
The American Journal of Gastroenterology|June 3, 2005
Will a 5-ASA a day keep the cancer (and dysplasia) away?David T Rubin, Bret A Lashner
The American Journal of Gastroenterology|June 8, 2021
Response to Tetangco and HanauerSeth R Shaffer, David T Rubin
The Medical Clinics of North America|December 1, 2009
Novel diagnostic and prognostic modalities in inflammatory bowel diseaseTimothy L Zisman, David T Rubin
Gastroenterology Clinics of North America|November 17, 2009
Novel diagnostic and prognostic modalities in inflammatory bowel diseaseTimothy L Zisman, David T Rubin
The American Journal of Gastroenterology|April 8, 2015
Using a Treat-to-Target Management Strategy to Improve the Doctor-Patient Relationship in Inflammatory Bowel DiseaseDavid T Rubin, Noa Krugliak Cleveland
Gastrointestinal Endoscopy Clinics of North America|July 1, 2014
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel diseaseChristopher G Chapman, David T Rubin
Pageof 57